Market Overview
The
Global Bioresorbable Medical Material Market size is expected to reach a
value of USD 445.3 million in 2024, and it is further anticipated to reach a market
value of USD 1,139.5 million by 2033 at a
CAGR of 11.0%.
The global bioresorbable medical material market in the modern bioeconomy is growing fast because of its ever-growing demand to safely degrade materials inside the human body. As opposed to both PLA and PGA, which are commonly used for a wide variety of applications, including drug delivery systems and the medical implant itself, these are important biomaterials that offer many advantages by avoiding surgical removal of the product. The material will help in natural healing through debilitating potential complications and hence find increasing popularity for use in modern advanced medical services.
The increased demand by the aged population and the development in tissue engineering are acting as driving factors for the growth in the bioresorbable medical material market, resulting in large-scale development in the market. Furthermore, most bioresorbable implants are also used in orthopedic applications, which makes implantations safer without permanent devices in the body. The major players of the industry are involved in R&D to extend the application of these bioresorbable materials to more complex areas of applications.
The market for bioresorbable medical materials holds immense growth potential, especially in emerging markets such as the Asia Pacific. These regions are seeing rapid improvements in infrastructure within healthcare, increased demand for advanced medical technologies, and a rise in medical tourism that will cause the convergence of bioresorbable materials to rise.
Further, with continuous developments on the fronts of better biocompatibility and controlled degradation of bioresorbable polymers, new application areas have opened up in wound care, cardiovascular interventions, and soft tissue engineering. This expansion into diverse medical applications presents a lucrative growth opportunity for bioresorbable materials, as manufacturers can tailor their products to meet various clinical requirements across geographies.
The increased usage of bioresorbable implants, particularly in minimally invasive procedures due to the lessened need for removal surgery, is a positive trend driving the growth in demand within the bioresorbable medical material market. Another trend in this domain is that of using bioresorbable polymers in drug delivery systems since such polymers facilitate controlled and localized release mechanisms that are advantageous for targeted therapies in oncology and cardiology. Combined, these trends represent the strategic shift toward more sophisticated, patient-friendly treatments that constrain long-term healthcare costs and improve recovery outcomes, and that will continue to impact the market's direction over the next several years.
The strengths of bioresorbable medical materials include biocompatibility, natural degradation within the body, and applicability to many medical uses. Unlike their traditional implant counterparts, all these bioresorbable materials negate the requirement for additional surgery Schulz said Handok is targeting elderly patients and those with higher surgical risks in its marketing. Materials are also appropriate for orthopedic, cardiovascular, and drug delivery applications as the degradation profiles can be engineered to meet specific clinical needs.
These attributes have established resorbable materials as a popular choice for manufacturers and healthcare providers alike and set market growth in motion. However, there are limitations to the use of bioresorbable medical materials. These are about the high manufacturing costs and strict regulatory requirements. Indeed, due to the complexity of their fabrication processes, bioresorbable materials are more expensive than traditional materials, and their diffusion is bounded in price-sensitive areas.
The fact that regulatory agencies such as the FDA and the EMA have to ensure safety and efficacy also delays the approval of products, hindering how fast new materials can be circulated. These are the barriers to accessibility that reduce the pace of adoption, particularly for small healthcare providers and those emerging markets where funding for healthcare is limited.
The US Bioresorbable Medical Material Market
The US Bioresorbable Medical Material Market is projected to be valued at USD 145.7 million in 2024. It is expected to witness subsequent growth in the upcoming period as it holds USD 352.8 million in 2033 at a CAGR of 10.3%.
Growth in the U.S. bioresorbable medical material market is very remarkable, with enhanced development of medical technologies and a greater emphasis on minimally invasive procedures. A key trend that would be worthwhile to adopt would be the use of bioresorbable materials within orthopedic implants. Such usage would provide a safer and more durable approach for patients in terms of bone regeneration and would eliminate the possible need for future removal surgeries. With the aging population being an added accelerator to demand due to the high incidence of age-related conditions such as osteoporosis and degenerative joint diseases, an ideal market would supply bioresorbable solutions.
Also, there is a growing interest in bioresorbable drug delivery systems, particularly for cancer treatments and cardiovascular applications, as they allow for precise, very localized drug delivery with the capability for gradual resorption without further intervention. Increasing research, together with significant funding by government agencies and research institutions to explore applications of bioresorbable material in more medical segments, continues to strengthen the market growth in the U.S. Medical device manufacturers all over the country have involved heavy investments in research and innovations related to PLA and PGA for developing, in turn, other value-added, bioresorbable polymers with an excellent range in clinical applications. Focusing on the development of high-performance bioresorbable materials in an affordable manner, the bioresorbable medical material market of the U.S. is expected to register steady growth and hold a considerable share in the global market during the forecast period.
Bioresorbable Medical Material Market: Key Takeaways
- Global Market Value: The Global Bioresorbable Medical Material Market size is estimated to have a value of USD 445.3 million in 2024 and is expected to reach USD 1,139.5 million by the end of 2033.
- The US Market Value: The US Bioresorbable Medical Material Market is projected to be valued at USD 145.7 million in 2024. It is expected to witness subsequent growth in the upcoming period as it holds USD 352.8 million in 2033 at a CAGR of 10.3%.
- Regional Analysis: North America is expected to have the largest market share in the Global Bioresorbable Medical Material Market with a share of about 38.9% in 2024.
- Key Players: Some of the major key players in the Global Bioresorbable Medical Material Market are Evonik Industries AG, Corbion N.V., DSM Biomedical, Ashland Global Holdings Inc., Foster Corporation, Poly-Med Inc., KLS Martin Group, Lactel Absorbable Polymers, and many others.
- Global Growth Rate: The market is growing at a CAGR of 11.0 percent over the forecasted period.
Bioresorbable Medical Material Market: Use Cases
- Orthopedic Implants: Biomaterials like PLA and PGA have great potential in developing applications for orthopedic implants involving the fixation of bones and joints. These implants tend to degrade naturally with time, thereby helping in the body's regeneration processes of tissues without the need for removal surgeries or additional patient risk.
- Drug Delivery Systems: Major applications of bioresorbable polymers in drug release methods involve the delivery of drugs locally to a specific area in the human body. Therefore, this is of main importance in cancer treatment, as it can reduce side effects by localized administration and enhance efficiency.
- Tissue Engineering Scaffolds: In regenerative medicine, bioresorbable plastics form the scaffold over which cell growth is supported for the purposes of tissue engineering in wound healing or organ repair. These materials support natural regeneration and degrade as new tissue forms.
- Cardiovascular Stents: These are bioresorbable stents that would temporarily support the blood vessels and then finally dissolve. This would eliminate complications associated with permanent implants, as well as negate the need for long-term medication.
Bioresorbable Medical Material Market: Dynamic
Trends in the Bioresorbable Medical Material Market
Increased Adoption of Bioresorbable ImplantsThe demand for bioresorbable implants has increased significantly owing to the increasing predisposition of health professionals toward less invasive procedures. Implants made from materials that degrade with time in the body, thereby avoiding possible removal surgery complications that can further deteriorate a patient's health condition, are called bioresorbable implants. Such a trend has been most witnessed in fully developed healthcare infrastructure regions like North America and Europe, where bioresorbable materials are well-documented and often used.
The bioresorbable implant, therefore, gains favor within orthopedics and cardiovascular surgery, as it allows the body to naturally heal itself around the implant over a certain period. New applications and increased rates, therefore, are likely to drive the central role in bioresorbable medical material market growth going forward.
Advancements in Drug Delivery Systems
Biodegradable polymers, especially PLA and PGA, have significantly changed the face of drug delivery with their controlled and localized release mechanisms. The development permits the addressing of conditions in oncology, cardiology, and other areas of concern with reduced systemic side effects, enhancing the therapeutic outcome. The versatility of such polymers in formulating exact drug delivery profiles has spurred demand in various applications.
The bioresorbable medical material markets are therefore on the rise, with work being carried out to tailor appropriate polymers such as PLA and PGA for desired degradation timelines, hence making them suitable for specific course treatments. This trend is likely to continue in the future and open more niches for bioresorbable drug delivery systems with increased specificity.
Growth Drivers in the Bioresorbable Medical Material Market
Rising Aging Population
With the aging of the population worldwide, conditions necessitating surgical interventions, such as osteoporosis and cardiovascular diseases, have been on the rise. Bioresorbable materials have the potential to better serve the elderly population, who face higher risks associated with surgical complications and longer recovery times in general.
These materials dissolve safely in the body and can help reduce follow-up surgeries due to conventional permanent devices. This demographic transition has ensured that the bioresorbable medical material market reaps benefits, with healthcare systems around the world striving to provide solutions friendly to unique health challenges faced by elderly populations.
Innovations in Tissue Engineering and Orthopedic Applications
Tissue engineering and orthopedic applications are considered lucrative segments of the bioresorbable medical material market and will continue to spur research and development in this direction. Much effort is being channeled into the manufacture of bioresorbable polymers with mechanical and chemical properties that meet the needs required for many of the very intricate procedures one can think of-such as bone repair or tissue regeneration.
Such inventions make it possible to use and incorporate bioresorbable materials into procedures where conventionally, permanent implants would be required. Developments of this sort allow bioresorbable materials to answer new medical needs, hence widening their market perspectives. As long as R&D continues to be able to provide materials with improved compatibility and functionality, the bioresorbable medical material market may reach a state of sustainable growth in the future.
Growth Opportunities in the Bioresorbable Medical Material Market
Expansion in Emerging Markets
Large growth opportunities for the bioresorbable medical material market exist, especially in emerging markets where healthcare infrastructure is improving and healthcare expenditure is rising. For instance, China, India, and Southeast Asia record improvements in healthcare infrastructure and increased healthcare spending. Such developments are driving demand for a range of advanced medical technologies, including bioresorbable materials. Furthermore, developing markets are increasingly emerging concerning medical tourism, that is, private patients seeking quality yet affordable care.
This emerging trend is encouraging bioresorbable material suppliers from all over the world to expand their operations in such a way as to cash in on the increasing demand. As healthcare standards continue to improve across the emerging markets, the demand for bioresorbable solutions will keep growing at an impressive rate and, therefore, present one of the most attractive opportunities for the market players.
Development of Advanced Bioresorbable Polymers
The development of fully bioresorbable polymers with enhanced biocompatibility, controllable degradation rates, and mechanical properties opens new perspectives for a wide range of medical applications. Within polymer chemistry, innovations are being taken toward predictable degradation of the material, such materials holding great promise in wound care, cardiovascular interventions, and soft tissue engineering.
This is a step forward that enables the manufacturer to cater to various needs of disparate fields and thus expands the scope of the bioresorbable medical material market. Hence, with such next-generation polymers, the market is expecting more customized and application-specific material development, driving further adoptions which in turn will grow the market further.
Restraints in the Bioresorbable Medical Material Market
High Costs of Bioresorbable Materials
Manufacturing bioresorbable polymers, such as PLA and PGA, is extremely expensive due to complicated manufacturing and very strict quality control for medical-grade materials. These increase the costs of bioresorbable materials above those of traditional materials, which again diminishes their affordability in cost-sensitive markets. High costs in emerging regions with constrained healthcare budgets may inhibit widespread adoption, and this can hamper market expansion.
Moreover, these cost-related constraints may affect research institutes and manufacturers of medical devices, which then have to balance quality with affordability, thus further impinging on the growth of the bioresorbable medical material market.
Regulatory Challenges and Approval Delays
Regulatory approval for bioresorbable materials is quite complicated and costly. Different medical regulatory bodies in the market, such as the FDA in the United States and the EMA in Europe, have very high standards when it comes to the safety and efficiency of such products. The process of satisfying such standards can delay the entry of new bioresorbable products into the market and, therefore, lengthen innovation cycles and dampen market growth.
Besides this, there is a need for bioresorbable medical material to demonstrate not only clinical efficacy but also predictably degrade within the body, which makes regulatory approval all the more difficult. Stringent regulatory requirements of this tendency may further keep smaller players away and slow down the market dynamics, which acts as a barrier to market growth.
Research Scope and Analysis
By Product Type Analysis
Polylactic acid (PLA) is projected to be the dominant product type in the bioresorbable medical material market as it will hold 24.1% of the market share in 2024. PLA is the title of the major product type in the bioresorbable medical material market due to some excellent properties such as biocompatibility, biodegradability, and broad versatility for several medical applications. PLA naturally obtained, hence, is an environment-friendly polymer that degrades inside the body into lactic acid-that natural substance which is already naturally metabolized by the human body-thereby being highly biocompatible and safe for implantation.
Due to its structural strength and controllable degradation rate, PLA is particularly suitable for various orthopedic applications, from devices used for bone fixation and sutures. Such a property allows the PLA-based material to maintain mechanical integrity during the initial stages of repair and degrade subsequently at a controlled rate, thereby allowing the natural repair of tissues to proceed without any foreign body remaining in the body. PLA also sees wide applications in drug delivery systems, especially those for control and local release purposes, aiding patients receiving oncological and cardiovascular treatments through the reduction of systemic treatments.
PLA would, therefore, have much say in the market in the future, considering such cost-effectiveness coupled with high production scalability and wide adaptability to many new medical applications. Growing research emphasis by various medical equipment producers and research institutions underlines the importance of PLA and its position in the bioresorbable medical material market. The market could also boost growth further with PLA-based material improvement and thereby make big contributions to the bioresorbable medical material market share.
By Application Analysis
Orthopedic devices are expected to represent the largest application segment in the bioresorbable medical material market as it holds 32.2% of the market share in 2024. The orthopedic devices represent the largest application segment in the bioresorbable medical material market, on account of the high demand for supportive bioresorbable implants that would help bone healing and joint repair. Due to an increasing aging population, age-related orthopedic abnormalities, like osteoporosis and degeneration of joints, become common, thereby increasing the use of bioresorbable medical materials aiding in bone regeneration and avoiding surgery.
The most commonly used bioresorbable materials, PLA and PGA, are widely used for orthopedic screws, pins, and plates because they provide temporary structural support while the bone is healing and then slowly resorb, minimizing long-term complications. These materials can significantly facilitate minimal invasiveness by avoiding secondary surgeries. This is particularly important in elderly patients, since rationalization of multiple surgeries may avoid additional risks.
Growth in the orthopedic segment is also driven by rising innovation in orthopedic surgical procedures and increased focus on superior levels of patient-oriented care. Key market participants are also aggressively developing and commercializing bioresorbable orthopedic devices to be used in conjunction with quicker recoveries, enhanced safety, and lower healthcare costs. This closest attention to orthopedic applications will more than likely position the orthopedic device as the dominant segment in terms of continuing to drive segmental growth and overall market share within the bioresorbable medical material market.
The Bioresorbable Medical Material Market Report is segmented on the basis of the following
By Product Type
- Polylactic Acid (PLA)
- Polyglycolic Acid (PGA)
- Polycaprolactone (PCL)
- Polydioxanone (PDO)
- Polyhydroxyalkanoates (PHA)
- Polyurethane (PU)
- Others
By Application
- Orthopedic Devices
- Drug Delivery
- Tissue Engineering
- Cardiovascular Devices
- Wound Management
- Other Application
Regional Analysis
Asia Pacific is projected to emerge as the dominant region in the global bioresorbable medical material market as it commands over
43.2% of the market share in 2024. The developing advanced healthcare infrastructure growth, together with enhanced healthcare expenditure and substantial investments in medical technology, has finally made the Asia Pacific the key player in the global bioresorbable medical material market.
The key countries of the regional market include China, India, and Japan due to the increase in demand for minimally invasive procedures. Besides that, there is a proactive healthcare system that favors the adoption of bioresorbable medical materials. The surge in chronic diseases, aging populations, and a preference for high-value patient care causes fewer follow-on surgeries as a result of the fact that bioresorbable materials dissolve and hence need not be removed to drive the demand for bioresorbables. As a result, therefore, these countries are seeing increased use of cardiovascular, orthopedic, and wound care devices.
Besides, medical tourism has turned into another important growth driver in the Asia-Pacific region, especially in countries like India, Thailand, and Malaysia which have emerged as global healthcare destinations. These locations attract patients from all over the world for high-quality treatments at lesser costs and usually with advanced technologies such as bioresorbable implants and materials. This has led to an influx of international patients, compelling healthcare providers to incorporate advanced materials in their facilities to meet the standards of other countries. The market for absorbable medical materials is growing accordingly in response.
This is evidenced by regional governments and institutions increasingly investing in R&D initiatives to support the development and refinement of bioresorbable technologies, seeing them as a sustainable solution for healthcare needs. The support given by government agencies about clinical trials and research in biocompatibility only added to the encouragement of the pace of innovation in the development of such materials by enabling manufacturers to improve the safety and efficacy of such materials. Major device manufacturers in the region also recognize the advantages of bioresorbable materials, which have been incorporated into a set of applications that range from orthopedic implants to drug-delivery systems to vascular stents.
These investments will not only improve patient outcomes but also establish Asia Pacific as a leader in innovation for bioresorbable medical technologies. Specifically, given these factors, Asia Pacific will likely continue its leading role in the bioresorbable medical material market in the forecast period and contribute significantly to the projected CAGR of the global market. Setting the pace for future developments in the bioresorbable medical material market, advancements in material sciences and healthcare technology meet supportive policy environments and strong demand in healthcare.
By Region
North America
Europe
- Germany
- The U.K.
- France
- Italy
- Russia
- Spain
- Benelux
- Nordic
- Rest of Europe
Asia-Pacific
- China
- Japan
- South Korea
- India
- ANZ
- ASEAN
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of Latin America
Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Egypt
- Rest of MEA
Competitive Landscape
The medical bioresorbable material market is very competitive. Key players in this industry are focusing on innovations in the development of advanced bioresorbable polymers and in expanding their product portfolios. The leading companies dominating the market include three well-known players: Medtronic, Johnson & Johnson, and Stryker. They are all investing heavily in R&D to enhance the bioresorbable properties of their product series to secure better patient outcomes and command a big share of the market.
Strategic collaboration and acquisition are the key strategies resorted to by them for a strong position in the market for bioresorbable medical materials. Companies forge partnerships with research institutes for faster development of next-generation bioresorbable materials that would meet the exacting needs of applications involving orthopedic systems and drug delivery systems. Such trends contribute toward market growth since the pace of innovation quickens, thus substantially reducing the time to market new products.
The entry of emerging participants also enters the market, supported by the increasing demand for bioresorbable medical materials and growing healthcare infrastructure in the Asia Pacific and other emerging economies. Competitive pricing and focusing on niche applications have become part of their strategy and probably mark the competition in the field more intensely. Therefore, the competitive scenario of the bioresorbable medical material market is highly dynamic and the participating companies will strive for technological improvement and geographical expansion.
Some of the prominent players in the Global Bioresorbable Medical Material Market are
- Evonik Industries AG
- Corbion N.V.
- DSM Biomedical
- Ashland Global Holdings Inc.
- Foster Corporation
- Poly-Med Inc.
- KLS Martin Group
- Lactel Absorbable Polymers (Direct Corporation)
- Helios Medical Materials
- Putnam Plastics Corporation
- Abbott Laboratories
- Zimmer Biomet Holdings, Inc.
- Other Key Players
Recent Developments
- November 2024: Medtronic announced the launch of a new bioresorbable orthopedic implant using advanced polyglycolic acid (PGA), designed to support bone regeneration while reducing post-surgical risks.
- September 2024: Stryker introduced a bioresorbable stent for cardiovascular applications, aiming to improve the safety profile for patients with arterial blockages.
- July 2024: Johnson & Johnson completed its acquisition of a bioresorbable materials startup to enhance its product portfolio in bioresorbable drug delivery systems and expand its R&D capabilities.
- May 2024: Boston Scientific received FDA approval for a bioresorbable drug-eluting stent, marking a significant milestone for the company in cardiovascular applications.
- March 2024: A research institute in Japan partnered with a leading medical device manufacturer to co-develop bioresorbable materials for tissue engineering applications.
- January 2024: The University of Cambridge collaborated with a European bioresorbable materials company to explore new applications of PLA in wound care and orthopedic devices, highlighting innovations in bioresorbable technology.
Report Details
| Report Characteristics |
| Market Size (2024) |
USD 445.3 Mn |
| Forecast Value (2033) |
USD 1,139.5 Mn |
| CAGR (2024-2033) |
11.0% |
| Historical Data |
2018 – 2023 |
| The US Market Size (2024) |
USD 145.7 Mn |
| Forecast Data |
2025 – 2033 |
| Base Year |
2023 |
| Estimate Year |
2024 |
| Report Coverage |
Market Revenue Estimation, Market Dynamics, Competitive Landscape, Growth Factors and etc. |
| Segments Covered |
By Product Type (Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polycaprolactone (PCL), Polydioxanone (PDO), Polyhydroxyalkanoates (PHA), Polyurethane (PU), and Others), By Application (Orthopedic Devices, Drug Delivery, Tissue Engineering, Cardiovascular Devices, Wound Management, and Other Application) |
| Regional Coverage |
North America – The US and Canada; Europe – Germany, The UK, France, Russia, Spain, Italy, Benelux, Nordic, & Rest of Europe; Asia- Pacific– China, Japan, South Korea, India, ANZ, ASEAN, Rest of APAC; Latin America – Brazil, Mexico, Argentina, Colombia, Rest of Latin America; Middle East & Africa – Saudi Arabia, UAE, South Africa, Turkey, Egypt, Israel, & Rest of MEA
|
| Prominent Players |
Evonik Industries AG, Corbion N.V., DSM Biomedical, Ashland Global Holdings Inc., Foster Corporation, Poly-Med Inc., KLS Martin Group, Lactel Absorbable Polymers (Durect Corporation), Helios Medical Materials, Putnam Plastics Corporation, Abbott Laboratories, Zimmer Biomet Holdings Inc., and Other Key Players |
| Purchase Options |
We have three licenses to opt for: Single User License (Limited to 1 user), Multi-User License (Up to 5 Users) and Corporate Use License (Unlimited User) along with free report customization equivalent to 0 analyst working days, 3 analysts working days and 5 analysts working days respectively. |
Frequently Asked Questions
The Global Bioresorbable Medical Material Market size is estimated to have a value of USD 445.3 million in 2024 and is expected to reach USD 1,139.5 million by the end of 2033.
The US Bioresorbable Medical Material Market is projected to be valued at USD 145.7 million in 2024. It is expected to witness subsequent growth in the upcoming period as it holds USD 352.8 million in 2033 at a CAGR of 10.3%.
Asia Pacific is expected to have the largest market share in the Global Bioresorbable Medical Material Market with a share of about 43.2% in 2024.
Some of the major key players in the Global Bioresorbable Medical Material Market are Evonik Industries AG, Corbion N.V., DSM Biomedical, Ashland Global Holdings Inc., Foster Corporation, Poly-Med Inc., KLS Martin Group, Lactel Absorbable Polymers, and many others.
The market is growing at a CAGR of 11.0 percent over the forecasted period.